Peptilogics
Pittsburgh, Pennsylvania, United States · Biotechnology · 22 employees
Peptilogics is developing therapeutics for orthopedic hardware-related infections. The company's lead candidate, zaloganan (PLG0206), is an investigational treatment for prosthetic joint infections currently in clinical development.
Funding history
- Series series b — $78.0M — Oct 2025
- Funding Round — $35.8M — Dec 2020
- Series seed — $4.0M — Aug 2017
- Series seed — $417K — Jan 2016
Recent signals
- Oct 16, 2025: Raised $78.0M in Series series b
- Dec 30, 2020: Raised $35.8M
- Aug 31, 2017: Raised $4.0M in Series seed
- Jan 21, 2016: Raised $417K in Series seed
See plans & pricing → Track Peptilogics’s funding, hiring, and signals — with verified contacts — on Fundz.